Brief: Redcare Pharmacy Reports Eur 420 Million In Total Sales In Q2, Up 46%

Redcare Pharmacy NV

01/08/2023 05:37

Aug 1 (Reuters) - Redcare Pharmacy Nv  RDC.DE :
    * EQS-NEWS: REDCARE PHARMACY Q2 2023: WHILE FAST SALES
GROWTH
CONTINUES UNABATED AT 46%, ADJUSTED. EBITDA MARGIN IMPROVED
5.3PP YEAR OVER YEAR TO 3.2%. COMPANY RAISES FULL-YEAR GUIDANCE.
    * FULL-YEAR GUIDANCE RAISED: NON-RX SALES GROWTH 20-30% (UP
FROM
10-20%); ADJUSTED. EBITDA MARGIN 1.5-3% (UP FROM 0.5-2.5%)
    * FULL-YEAR GUIDANCE RAISED: SEES TOTAL NET SALES EUR
1.7-1.8
BILLION
    * TOTAL SALES UP 46% IN Q2 TO EUR 420M AND BY 34% IN H1 TO
EUR
792M.
    * ADJUSTED EBITDA FOR H1 2023 IMPROVED YEAR OVER YEAR, UP
EUR 32.4
MILLION FROM EUR -10.4 MILLION IN H1 2022 TO EUR 22 MILLION
    * GROUP'S EBIT IMPROVED YEAR OVER YEAR FROM EUR -41 MILLION
TO EUR
-9.8 MILLION IN H1 2023

Source text for Eikon:  ID:nEQ22hmGPa 
Further company coverage:  RDC.DE 

 ((Reuters.Briefs@thomsonreuters.com;))